Nihon Kohden (TSE:6849) ROCE % : 1.62% (As of Dec. 2023)

View and export this data going back to 1961. Start your Free Trial

What is Nihon Kohden ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nihon Kohden's annualized ROCE % for the quarter that ended in Dec. 2023 was 1.62%.

Nihon Kohden ROCE % Historical Data

The historical data trend for Nihon Kohden's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nihon Kohden ROCE % Chart

Nihon Kohden Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

13.23

11.24

20.14

22.71

15.01

Nihon Kohden Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															2.22	25.92	13.55	15.48	1.62

Nihon Kohden ROCE % Calculation

Nihon Kohden's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	24726	/	( ( (210201 - 50804)	+	(216728 - 46568) )	/ 2 )
	=	24726	/	( (159397	+	170160)	/ 2 )
	=	24726	/	164778.5
	=	15.01 %

Nihon Kohden's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	2844	/	( ( (220990 - 44161)	+	(215788 - 41929) )	/ 2 )
	=	2844	/	( ( 176829	+	173859 )	/ 2 )
	=	2844	/	175344
	=	1.62 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Nihon Kohden (TSE:6849) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nihon Kohden ROCE % Related Terms

Thank you for viewing the detailed overview of Nihon Kohden's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nihon Kohden (TSE:6849) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nihon Kohden Corp (TSE:6849) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

NHNKY:USA

Address

31-4 Nishiochiai 1-chome, Shinjuku-ku, Tokyo, JPN, 1618560

Website

http://www.nihonkohden.co.jp

Nihon Kohden Corp manufactures electronic medical equipment. The firm operates in four categories: physiological measuring equipment, treatment equipment, patient monitors, and other medical equipment. The patient monitors segment contributes the largest proportion of revenue and includes continuous monitoring instruments and clinical information systems. The physiological measuring equipment segment sells electroencephalographs, electrocardiographs, and diagnostic information systems. The treatment equipment segment sells defibrillators, pacemakers, ventilators, and related consumables. The other medical equipment segment sells automated hematology analyzers, ultrasound diagnostic equipment, and other laboratory equipment. Nihon Kohden generates the majority of its revenue in Japan.

Nihon Kohden (TSE:6849) Headlines

No Headlines